Event Details

Event Introduction
This R&D presentation will offer the CanCham business community – and specifically those involved in China-based manufacturing, research and innovation – a fantastic opportunity to learn how to access or enhance tax savings that may be critical to corporate expenses for small-and-medium sized companies and worth millions each year to larger CanCham members.

Chinese government authorities recently enhanced opportunities for companies to access the 150% Super Deduction across many industries, including manufacturing, banking, engineering, automotive, pharma etc. Circular 119 (the recently released SAT tax guidance circular) includes a number of new features that companies should be aware of in order to maximise returns on investment.

The High and New Technology Enterprise (HNTE) regulation is also under policy review with regulatory announcements imminent regarding this key program. The proposed HNTE regulation change will impact current compliance procedures, and understanding these HNTE trends will give companies time to prepare in advance.

About The Seminar:
  • Focus on recent changes to the 150% Super Deduction program and upcoming changes to HNTE regulations
  • Provide practical engineering and scientific explanations to help companies clearly understand their entitlements
  • Highlight case studies of our most recent dealings with the Science and Tax bureaus across China when dealing with super deduction and HNTE applications
  • Flag ‘pitfalls’ and ‘opportunities’ from a tax and engineering perspective
Analyse other key requirements such as: IP ownership, contract R&D, reporting, transfer pricing, record keeping, potential intra-group recharges and other potential issues


  • Alan Garcia (Partner at KPMG)

    Alan Garcia

    Partner at KPMG

    Alan specializes in identifying all material R&D activities and associated R&D expenditure. This includes the provision of tailored knowledge transfer workshops and extensive analyses and processing of financial data – including understanding IP location issues, cross-charge/reimbursement across jurisdictions and associated financial risk.

    Currently focuses on the Chinese R&D Super Deduction and HNTE / ATSE incentives. Dealing with Chinese SAT / STB / MOF regulators regarding interpretation of R&D incentive rules and regulations; liaison with government regarding incentive policies, audit defence etc.

    view more